Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps
    Research study

    Piloting WHO’s Guidance: ‘Towards universal health coverage for preventive chemotherapy for neglected tropical diseases: guidance for assessing who is left behind and why’ in Kwara State, Nigeria

    On this page

    • Main objectives
    • Summary
    • Resources
    On this page
    • Main objectives
    • Summary
    • Resources

    Main objectives

    • To evaluate the revised draft of the WHO mainstreaming guidance on integrating a gender, equity and human rights focus into national programming on preventive chemotherapy and transmission (PCT) control for NTDs
    • To explore the practicality of using the tool to complete these activities

    Summary

    The WHO Gender, Equity and Rights (GER) toolkit was developed to address inequities in PC programming for individuals and households who are most affected by the burden of NTDs, particularly in rural settings. The GER tool kit was previously piloted in different settings and was then revised based on findings, necessitating a second pilot.

    This pilot study of the revised modular guidance document was carried out in four communities (two rural and two urban) drawn from two LGAs (Patigi and Irepodun) using both quantitative and qualitative approaches. Modules 1 and 2, involved organising relevant state level stakeholders, collating, reviewing analysing routinely collected gender and age disaggregated data from PCT monitoring in the two LGAs to identify potential availability, accessibility, acceptability and coverage issues. In Module 3 and 4, qualitative analysis comprising of focus group discussions and key informants interviews, in addition to joint analysis of data with relevant stakeholders and dissemination meetings were held.

    Resources

    Read the policy brief (pdf)
    GER Kwara Policy Brief – Final

    Related tags

    Neglected tropical diseases (NTDs general)
    Nigeria
    Study details
    Start date
    January 2018
    Finish date
    January 2020
    Main contact
    Joy Shuaibu
    Principal Investigator
    jshuaibu@sightsavers.org
    Partners
    • Nigeria Federal Ministry of Health
    • World Health Organization (WHO)
    • Liverpool School of Tropical Medicine
    Funders
    Sightsavers
    Countries
    Nigeria
    Themes/conditions
    Neglected tropical diseases (NTDs general)
    Study details
    Start date
    January 2018
    Finish date
    January 2020
    Main contact
    Joy Shuaibu
    Principal Investigator
    jshuaibu@sightsavers.org
    Partners
    • Nigeria Federal Ministry of Health
    • World Health Organization (WHO)
    • Liverpool School of Tropical Medicine
    Funders
    Sightsavers
    Countries
    Nigeria
    Themes/conditions
    Neglected tropical diseases (NTDs general)

    Related research studies

    Research study

    Facility assessment for lymphatic filariasis-morbidity management and disability accessibility in Ghana

    Research study

    Rapid assessment of behavioural factors associated with delivery and uptake of care and services related to lymphatic filariasis

    Research study

    Potential mitigating role of ivermectin on the spread of chlamydia trachomatis by Musca sorbens

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.